BENJAMIN F. EDWARDS & COMPANY, INC. - HEPION PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
BENJAMIN F. EDWARDS & COMPANY, INC. ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$01
-99.9%
0.00%
Q4 2022$0
-100.0%
1,0010.0%0.00%
Q3 2022$1,0000.0%1,0010.0%0.00%
Q2 2022$1,000
-83.3%
1,001
-77.8%
0.00%
Q1 2022$6,000
+20.0%
4,5010.0%0.00%
Q4 2021$5,000
-50.0%
4,501
-30.8%
0.00%
-100.0%
Q3 2021$10,000
-23.1%
6,5010.0%0.00%0.0%
Q2 2021$13,000
+116.7%
6,501
+116.6%
0.00%
Q1 2021$6,0003,001
+300000.0%
0.00%
Q4 2020$010.0%0.00%
Q3 2020$010.0%0.00%
Q2 2020$010.0%0.00%
Q1 2020$010.0%0.00%
Q4 2019$010.0%0.00%
Q3 2019$010.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 189,616$375,439,0001.17%
Ikarian Capital, LLC 1,365,059$2,703,0000.22%
Altium Capital Management LP 446,000$883,0000.20%
ASSET MANAGEMENT CORP /IL/ /ADV 91,500$181,0000.10%
Virtu Financial LLC 113,869$225,0000.02%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 10,000$20,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 155,069$307,0000.01%
McAdam, LLC 55,978$86,0000.01%
Moloney Securities Asset Management, LLC 27,340$54,0000.01%
Allen Capital Group, LLC 23,685$47,0000.01%
View complete list of HEPION PHARMACEUTICALS INC shareholders